Sources

5 Total Sources

FDA Fast-Tracks Daraxonrasib for Pancreatic Cancer After 15-Month Survival Data

UCHealth Today5h ago

FDA Fast-Tracks Daraxonrasib for Pancreatic Cancer After Doubling Survival Rates

Experimental drug doubles survival rates in advanced pancreatic cancer

thetownhall.news1d ago

Daraxonrasib Doubles Pancreatic Cancer Survival — What Patients Need to Know Now - The Town Hall News

erienewsnow.com1d ago

New Drug Offers Hope for Patients With Advanced Pancreatic Cancer | News | erienewsnow.com

Instagram5h ago

Daraxonrasib is a new drug is changing the face of pancreatic cancer care. For decades, pancreatic cancer often presented as a death sentence. But that may be changing now thanks to a